Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Famotidine vs Esomeprazole for Ulcer Prevention in ACS/MI Patients
NCT00683111Phase 4Completed
- Sponsor
- Ruttonjee Hospital
- Start
- Jul 2008
- Primary completion
- Dec 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of famotidine, esomeprazole in peptic ulcer disease (PUD), gastrointestinal bleeding, sponsored by Ruttonjee Hospital. Started Jul 2008; status: completed.
02
Drugs
famotidineesomeprazole
03
Conditions
peptic ulcer disease (PUD)gastrointestinal bleeding
Beyond the preview
Go deeper on NCT00683111.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00683111.